(Date:11/9/2009)...se action backs President Obama,s promise to not e...ample ,, Bishops still concerned for poor, el...wire/ -- Cardinal Francis George of Chicago, presi...ishops, lauded the November 7 decision of the U.S....care reform money from paying for elective abortio...
(Date:11/9/2009)...ped men and women almost equally, study finds, ,... widely used clot-dissolving drug Plavix (clopidog...nalysis of major clinical trials has found. , "... treating both men and women with this very import... cardiovascular thrombosis at New York University ...
(Date:11/9/2009)... improve letter formation could boost self-esteem,...lthDay News) -- Autistic children are more likely ...rming letters, than those without autism, research...aged 8 to 13. Half of the study participants had a...cored within the normal range for perceptual reaso...
(Date:11/9/2009)...ZHEN, China, Nov. 9 /PRNewswire-FirstCall/ - Hard ... announced today that Novartis, a US$41 billion in...% stake in HTDS, H1N1 Vaccine partner, Zhejiang Ti...llion. Novartis of Switzerland will begin a five-y...e company will dramatically increase its investmen...
(Date:11/9/2009)... New study highlights positive infl... Rosemont, IL (Vocus) Novembe...bone health decreases. Recent research has highlig...ments to help prevent these issues. However, a new... Sports Health: A Multidisciplinary Approach rev...
Breaking Medicine News(10 mins):Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2...xtend safety practices, CDC reports , , TH...ng for several years, reports of foodborne illness...ce 2004, federal health officials said Thursday. ,...all number of foodborne infections by 2010. , "Foo...
... 10, 2008) Carotid artery stenting is an effecti...ble for surgery, according to a long-term study pu...ine. Carotid artery disease, which involves cloggi...estimated 200,000 Americans each year who would ot...
...o world-leading companies have,come together to cr...A-,cleared, clinically proven light therapy techno...ate skin in the face and neck areas., (Logo: htt...ning beds, has partnered with Carlsbad, Calif.-,he...
...ers from the University of Pennsylvania School of ...signaling pathway, which determines the developmen...me cancers, is not universally essential for the m.... , Notch is one of a select set of proteins that...
... Surgery of the Head and Neck, NEW YORK, April 10...lizing in plastic and cosmetic surgery for the eth... Asian patients at a one day,Continuing Medical Ed..."Facial contouring, a commonly requested surgery a...
...nors and Mayors Support Event, ALEXANDRIA, Va., A...lthcare Decisions Day (NHDD), will be the largest,...rofessionals about,advance healthcare planning., ...e Decisions Day. "All Americans should use April 1...
Other Medicine News:Health News:Foodborne Illnesses Remain Constant in U.S. 2Health News:Foodborne Illnesses Remain Constant in U.S. 3Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 2Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 3Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 2Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 3Health News:Developing cancer treatments directed at critical developmental pathway 2Health News:Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar 2Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2